Commentary
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
-
Correspondence: Yoav Golan ygolan@tuftsmedicalcenter.org
Critical Care 2009, 13:180 doi:10.1186/cc7977
No comments have yet been made on this article.